SMC - Scientific Molding Corporation Ltd.
02/14/2025 | Press release | Archived content
Combining Human Needs With High Viscosity Formulations
Within the injectable drug landscape, the availability and usage of high viscosity (HV) drugs is growing, often driven by developments such as long-acting injectable (LAI) technologies. Currently, these products provide significant advantages in terms of more convenient dosage volumes for patients and healthcare professionals (HCPs). With a trend towards self-administration, LAIs allow for less frequent dosing thus promoting better patient compliance.
Download the Full Article
SMC - Scientific Molding Corporation Ltd. published this content on February 14, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on January 26, 2026 at 15:25 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]